Literature DB >> 25187120

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective.

L Hansen1, K D Petersen, S A Eriksen, B L Langdahl, P A Eiken, K Brixen, B Abrahamsen, J-E B Jensen, T Harsløf, P Vestergaard.   

Abstract

SUMMARY: Fractures after the age of 50 are frequently observed in Denmark, and many of these may be osteoporotic. This study examined the incidence of all and subsequent fractures in a 10-year period from 2001 to 2011. The incidence of subsequent fractures was high, especially following hip fracture.
INTRODUCTION: The purpose of this study is to examine patterns of subsequent fractures and mortality rates over a 10-year period in patients already suffering from fracture.
METHODS: The study was designed as a nationwide, register-based follow-up study. Patients were included if diagnosed with an index fracture (ICD-10 codes: S22.x, S32.x, S42.x, S52.x, S62.x, S72.x, S82.x, S92.x, T02.x, T08.x, T10.x and T12.x) between January 1st, 2001 and December 31st, 2001 and if older than 50 years at time of fracture. The patients were investigated for future subsequent fractures from January 1st, 2002 to December 31st, 2011.
RESULTS: In this study, we demonstrated that patients with fractures (especially hip fractures) have a high risk of subsequent fractures, especially hip fracture. Other fractures, which are not commonly considered as osteoporotic fractures, such as lower leg, were frequently observed in the 10 years following index fracture. The cumulative incidence proportion (CIP) of subsequent fractures during the 10-year follow-up period was high for all recurrent fractures (9-46 %). Subsequent hip fracture, regardless of index fracture, had the highest CIP across the study period, ranging from 9 to 40 %. Appendicular fractures were often followed by a recurrent fracture, or subsequent fractures at a more proximal location in the same limb, i.e. forearm fractures were followed by humerus fractures. These results have not been previously demonstrated to this extent, and according to our knowledge, no previous studies have estimated cumulative 10-year subsequent fracture incidences for any non-hip fractures.
CONCLUSION: Patients suffering a fracture (and especially a hip fracture) have a high incidence of subsequent fracture. Fractures after the age of 50 may be considered an early warning of increased risk for future fractures in many patients.

Entities:  

Mesh:

Year:  2014        PMID: 25187120     DOI: 10.1007/s00198-014-2875-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

Review 1.  The role of falls in fracture prediction.

Authors:  Heike A Bischoff-Ferrari
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

2.  Costs and quality of life associated with osteoporosis-related fractures in Sweden.

Authors:  Fredrik Borgström; Niklas Zethraeus; Olof Johnell; Lars Lidgren; Sari Ponzer; Olle Svensson; Peter Abdon; Ewald Ornstein; Karl Lunsjö; Karl Göran Thorngren; Ingemar Sernbo; Clas Rehnberg; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2005-11-09       Impact factor: 4.507

3.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

4.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

5.  Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Authors:  Charles H Chesnut; Arne Skag; Claus Christiansen; Robert Recker; Jacob A Stakkestad; Arne Hoiseth; Dieter Felsenberg; Hermann Huss; Jennifer Gilbride; Ralph C Schimmer; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

6.  Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study.

Authors:  Bo Abrahamsen; Pia Eiken; Richard Eastell
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

7.  Prior fractures are common in patients with subsequent hip fractures.

Authors:  Beatrice J Edwards; Andrew D Bunta; Christine Simonelli; Mark Bolander; Lorraine A Fitzpatrick
Journal:  Clin Orthop Relat Res       Date:  2007-08       Impact factor: 4.176

8.  [The national patient registry. Evaluation of data quality].

Authors:  J Mosbech; J Jørgensen; M Madsen; K Rostgaard; K Thornberg; T D Poulsen
Journal:  Ugeskr Laeger       Date:  1995-06-26

9.  Osteoporotic fracture: missed opportunity for intervention.

Authors:  Leah Port; Jacqueline Center; N Kathy Briffa; Tuan Nguyen; Robert Cumming; John Eisman
Journal:  Osteoporos Int       Date:  2003-08-07       Impact factor: 4.507

10.  10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.

Authors:  Anthony B Hodsman; William D Leslie; James F Tsang; Greg D Gamble
Journal:  Arch Intern Med       Date:  2008-11-10
View more
  14 in total

1.  Social inequality and fractures-secular trends in the Danish population: a case-control study.

Authors:  L Hansen; A Judge; M K Javaid; C Cooper; P Vestergaard; B Abrahamsen; N C Harvey
Journal:  Osteoporos Int       Date:  2018-06-26       Impact factor: 4.507

2.  Characteristics of recurrent fractures.

Authors:  J A Kanis; H Johansson; A Odén; N C Harvey; V Gudnason; K M Sanders; G Sigurdsson; K Siggeirsdottir; L A Fitzpatrick; F Borgström; E V McCloskey
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

3.  Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.

Authors:  L Hansen; K D Petersen; S A Eriksen; F Gerstoft; P Vestergaard
Journal:  Osteoporos Int       Date:  2016-07-30       Impact factor: 4.507

4.  Risk factors for subsequent vertebral fractures following a previous hip fracture.

Authors:  Sang-Min Park; Sung Jun Go; Heesoo Han; Jung Wee Park; Young-Kyun Lee; Ho-Joong Kim; Jin S Yeom; Kyung-Hoi Koo
Journal:  J Bone Miner Metab       Date:  2020-07-18       Impact factor: 2.626

5.  Imminent risk of fracture after fracture.

Authors:  H Johansson; K Siggeirsdóttir; N C Harvey; A Odén; V Gudnason; E McCloskey; G Sigurdsson; J A Kanis
Journal:  Osteoporos Int       Date:  2016-12-27       Impact factor: 4.507

6.  Incidence of different types of subsequent fractures and related mortality in Taiwan.

Authors:  Jiun-Liang Chen; Ta-Wei Tai; Che-Yi Chou; Chieh-Ko Ku; Li-Nien Chien; Tsan-Wen Huang; Chao-Hsuin Tang
Journal:  Arch Osteoporos       Date:  2022-04-01       Impact factor: 2.617

Review 7.  Importance of Recent Fracture as Predictor of Imminent Fracture Risk.

Authors:  Amanda D Schnell; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

8.  Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures.

Authors:  J A Kanis; H Johansson; N C Harvey; V Gudnason; G Sigurdsson; K Siggeirsdottir; M Lorentzon; E Liu; L Vandenput; E V McCloskey
Journal:  Osteoporos Int       Date:  2020-07-01       Impact factor: 4.507

Review 9.  Approaches to Fracture Risk Assessment and Prevention.

Authors:  Sanford Baim; Robert Blank
Journal:  Curr Osteoporos Rep       Date:  2021-02-01       Impact factor: 5.096

10.  Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors:  L Iconaru; M Moreau; F Baleanu; V Kinnard; A Charles; A Mugisha; M Surquin; F Benoit; R Karmali; M Paesmans; J J Body; P Bergmann
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.